We are a top site for some of the most advanced radiopharmaceutical trials in the world. Explore innovative imaging opportunities and potentially life-saving therapies for diseases like prostate cancer, pancreatic cancer, small cell lung cancer, and many others. Clinical trial patients can expect the same exceptional care and attention as our standard treatment patients.
- Access to radiopharmaceutical imaging agents
- Access to radiopharmaceutical therapies
- Highest level of clinical safety practices
- Highest quality patient experience
- World-class Theranostics experts
- Complimentary on-site valet parking
BAMF Health is working every day to conduct additional clinical trials to improve disease management using molecular imaging and molecularly targeted radiation therapy.
Clinical Trial General Interest Copy link
If you are interested in learning more about participating in a clinical trial, please fill out this form.
Clinical Trial Updates
BAMF Health Doses First Patient in the U.S. in Phase 2b Imaging Study of Brain Metastasis
BAMF Health dosed the first patient in the U.S. for Radiopharm Theranostics’ Phase 2b imaging study of 18F-RAD101 in suspected recurrent brain metastasis.
April 28, 2025
BAMF Health seeks breast cancer patients for groundbreaking imaging study
This non-invasive clinical trial aims to understand the prevalence of a specific biomarker in HR-/HER2+ breast cancer.
April 24, 2025
Fueled by Hope and the Open Road
David was the first person in the United States to receive a new experimental agent to treat pancreatic cancer.
January 22, 2025